Melissa McCarthy debuted a visibly slimmer physique while hosting Saturday Night Live Dec. 6, with many fans complimenting ...
As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...
Franklin The Turtle was co-opted by Team Trump and now our childhoods are ruined. We’ve all reached our breaking point with ...
Global shortages of GLP-1 drugs like Ozempic and Wegovy are piling pressure on pharmaceutical manufacturing and supply chains ...
Hims and Hers first announced its expansion into Canada in early July, taking the opportunity as Danish pharmaceutical giant ...
Base shelf prospectus is accessible, and prospectus supplement will be accessible for CAD$ offering within two business days, ...
Scientists are testing a GLP-1-based injection, similar to Ozempic, to see whether it can help overweight cats manage obesity ...
The telehealth provider Hims & Hers Health has launched an aggressive dual acquisition strategy, signaling a major ...
Shares of telehealth provider Hims & Hers were up more than 5% Thursday morning after the company said it started serving customers in Canada, a sign of its plan to capitalize on international demand ...
One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it ...
Weight loss drugs may still help to fight against Alzheimer’s disease, despite a study by the manufacturer of Ozempic showing ...
Delhi HC permits Dr Reddy's to export generics of Novo Nordisk's semaglutide, rejecting patent claims and addressing evergreening concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results